Say hello to MassDevice +3, a bite-sized view of the top three med-tech stories of the day. This latest feature of MassDevice.com’s coverage highlights our three biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry.
If you read nothing else today, make sure you’re still in the know with MassDevice +3.
Cook Medical touts a unanimous FDA panel recommendation for its Zilver PTX drug-eluting stent, which will be the first of its kind for treatment of femoropopliteal arteries in the U.S. once it’s approved.
Steve Jobs, the tech visionary and founder of Apple Inc. (NSDQ:AAPL) who died earlier this month after a long struggle with cancer, may have been saved had he stuck with conventional medicine, according to a cancer specialist.
Angel investment in new companies rose during the first half of 2011, according to the University of New Hampshire’s Center for Venture Research, even as early-stage venture capital funding declined, as reported by Dow Jones LP Source.